# Leflunomide to Treat Uveitis

> **NCT00001863** · PHASE2 · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 16 (—)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Leflunomide

## Key facts

- **NCT ID:** NCT00001863
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** —
- **Final completion:** 2003-02
- **Target enrollment:** 16 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001863, "Leflunomide to Treat Uveitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00001863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*